{"symbol": "PRTX", "name": "Protalex", "next_earnings_utc": 1593180000, "next_earnings_period_start_date_utc": 1582934400, "next_earnings_period_end_date_utc": 1590883200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": -0.07, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 0, "analysts_sell": null, "analysts_buy": null, "analysts_outperform": null, "analysts_hold": null, "analysts_underperform": null, "webpage": "protalex.com", "year_founded": 1999, "street_address": "131 Columbia Turnpike", "city": "Florham Park", "state": "NJ", "zipcode": "07932", "country": "United States", "phone_number": "215-862-9720", "short_description": "Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States.", "long_description": "Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase 1b clinical trial for the treatment of RA on methotrexate or leflunomide. The company was founded in 1999 and is based in Florham Park, New Jersey.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "Pink No Info", "equity_type": "stocks", "market_cap": 236626, "total_enterprise": null, "number_of_employees": 2, "outstanding_shares": 47325387, "eps": -0.121701, "diluted_eps": -0.121701, "earnings_from_cont_operations": -4647319, "gross_profit": null, "cash": 114876, "total_debt": null, "total_revenue": null, "cash_from_operations": -2937382, "net_income": null, "ebitda": null, "year_low_stock_price": 0.0015, "year_high_stock_price": 0.05, "seekingalpha_follower_count": 415, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/PRTX.png"}